Resistance to novel antimicrobial agents among NDM-and OXA-48-producing Carbapenem-resistant Enterobacterales in Lebanon
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1938955 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von George F Araj und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Microbiology Laboratory, Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon. Hauptthemen laut MEDLINE: beta-Lactamases, Carbapenem-Resistant Enterobacteriaceae, Escherichia coli, Anti-Bacterial Agents. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Rapid detection of carbapenemases and antimicrobial susceptibility testing (AMST) against carbapenem-resistant (CR) Enterobacterales (CRE) are key elements in controlling their nosocomial spread and useful to guide treatment of patients infected with such morbid pathogens. The absence of comprehensive data in Lebanon prompted this study.
Objective
This study aimed at revealing the carbapenemase types among CR isolates recovered from patients representing 100 Escherichia coli (CREc) and 40 Klebsiella pneumoniae (CRKp). Their antimicrobial resistance (AMR) profiles against routine and novel antimicrobial agents were also determined.
Methods
Identification of isolates was done by MALDI-TOF, and the types of carbapenemases were determined by the rapid NG-Test CARBA. Antimicrobial resistance (AMR) profiles were revealed against the routine antibiotics, including ceftazidime-avibactam, and novel antimicrobial agents that still have not been introduced in this country, namely, imipenem-relebactam, meropenem-vaborbactam, and cefiderocol using disk diffusion and standard Etest methods.
Results
Among both CREc and CRKp, the detected carbapenemases were only NDM and OXA-48, whereby the majority were NDM. The activity of novel antimicrobial agents was higher against CREc than CRKp isolates, and against OXA-48- producing strains than NDM-producing strains in both species.
Conclusion
This first comprehensive in vitro study from Lebanon revealed high resistance (28%-100%, and 0%-100% among NDM and OXA-48 producers, respectively) of yet-to-be- introduced novel antimicrobial agents in this country. This highlights the necessity of scrutinizing the proper use of antimicrobial agents, stewardship programs, and infection control aspects to curb the morbid impact of these pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Microbiology Laboratory, Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
- Center for Infectious Diseases Research, American University of Beirut Medical Center, Beirut, Lebanon.
- Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Zitieren
APA
Araj, G. F., Matar, J. M., Al Ghor, C. K., Sobh, G. M., & Dagher, C. R. (2026). Resistance to novel antimicrobial agents among NDM-and OXA-48-producing Carbapenem-resistant Enterobacterales in Lebanon. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1938955
Vancouver
Araj GF, Matar JM, Al Ghor CK, Sobh GM, Dagher CR. Resistance to novel antimicrobial agents among NDM-and OXA-48-producing Carbapenem-resistant Enterobacterales in Lebanon. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1938955
BibTeX
@article{Araj2026,
author = {Araj, George F and Matar, Joseph M and Al Ghor, Chaza K and Sobh, Ghena M and Dagher, Clara R},
title = {Resistance to novel antimicrobial agents among NDM-and OXA-48-producing Carbapenem-resistant Enterobacterales in Lebanon},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1938955}
}
EUVIMED